Targeting tumor-associated CCR2 + macrophages to inhibit pancreatic cancer recurrence following irreversible electroporation
Open Access
- 25 July 2025
- journal article
- materials science
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 11 (30) , eadw2937
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with pronounced resistance to conventional therapies. Irreversible electroporation (IRE) is a promising therapy for PDAC; however, its clinical efficacy is limited by a high recurrence rate. Here, using a preclinical PDAC model, we characterized the tumor immune microenvironment following insufficient IRE (iIRE) through single-cell RNA sequencing. We found that iIRE induces a CCR2 + tumor-associated macrophage (CCR2 + TAM)–mediated immunosuppressive microenvironment in residual tumors. Consequently, we developed a macrophage-based proteolipid vesicle (mPLV) coencapsulating the CCR2 antagonist PF-4136309 (PF) and gemcitabine (GEM), named PF/GEM@mPLV. Our findings suggest that PF/GEM@mPLV achieves high drug accumulation within tumors through iIRE-induced inflammation. Reduction of CCR2 + TAMs enhances antitumor immunity and improves chemotherapeutic response. PF/GEM@mPLV markedly inhibits tumor recurrence following iIRE, diminishes hepatic metastases, and prolongs survival in preclinical PDAC models. These findings uncover the role of CCR2 + TAMs in iIRE-induced immunosuppression, offering a promising strategy to enhance the clinical potential of IRE in PDAC.Keywords
This publication has 49 references indexed in Scilit:
- Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 PatientsAnnals of Surgical Oncology, 2015
- Metastases of pancreatic adenocarcinoma: A systematic review of literature and a new functional conceptInternational Journal of Surgery, 2015
- Treatment of 200 Locally Advanced (Stage III) Pancreatic Adenocarcinoma Patients With Irreversible ElectroporationAnnals of Surgery, 2015
- Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic ResponsesCancer Research, 2013
- Irreversible Electroporation in Locally Advanced Pancreatic Cancer: Potential Improved Overall SurvivalAnnals of Surgical Oncology, 2012
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- Advanced Hepatic Ablation Technique for Creating Complete Cell Death: Irreversible ElectroporationRadiology, 2010
- Irreversible Electroporation: A New Ablation Modality — Clinical ImplicationsTechnology in Cancer Research & Treatment, 2007
- Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2Nature Immunology, 2006
- Tissue Ablation with Irreversible ElectroporationAnnals of Biomedical Engineering, 2005